← Back to Search
Genetic Polymorphisms Of Human UDP-glucuronosyltransferase (UGT) Genes And Cancer Risk
D. G. Hu, P. Mackenzie, R. McKinnon, R. Meech
Published 2016 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Abstract Identification of genetic polymorphisms that contribute to the risk of developing cancers is important for cancer prevention. The most recent human genome GRCh38/hg38 assembly (2013) reveals thousands of genetic polymorphisms in human uridine diphosphoglucuronosyltransferase (UGT) genes. Among these, a large number of polymorphisms at the UGT1A and UGT2B genes have been shown to modulate UGT gene promoter activity or enzymatic activity. Glucuronidation plays an important role in the metabolism and clearance of endogenous and exogenous carcinogenic compounds, and this reaction is primarily catalyzed by the UGT1A and UGT2B enzymes. Therefore, it has long been hypothesized that UGT polymorphisms that reduce the capacity to glucuronidate carcinogens and other types of cancer-promoting molecules (e.g. sex hormones) are associated with an increased risk of developing cancers. A large number of case-control studies have investigated this hypothesis and these studies identified numerous UGT polymorphisms in UGT1A and UGT2B genes as genetic risk factors for a wide variety of cancers, including bladder, breast, colorectal, endometrial, esophageal, head and neck, liver, lung, prostate, and thyroid. These UGT polymorphisms may be cancer causative polymorphisms, or be linked to as yet undefined causative polymorphisms, either in UGT genes or neighboring genes. This article presents a comprehensive review of these case-control studies, discusses current areas of uncertainty, and highlights future research directions in this field.
This paper references
Differential allelic expression of c.1568C > A at UGT2B15 is due to variation in a novel cis-regulatory element in the 3'UTR.
C. Sun (2011)
UGT1A7 polymorphisms in chronic pancreatitis: an example of genotyping pitfalls
R. Morsche (2008)
Endogenous and exogenous factors in carcinogenesis: limits to cancer prevention
W. Lutz (1996)
Active Cigarette Smoking, Variants in Carcinogen Metabolism Genes and Breast Cancer Risk among Pre‐ and Postmenopausal Women in Ontario, Canada
M. Cotterchio (2014)
Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.
A. Vogel (2001)
Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer.
J. Araki (2005)
UDP-Glucuronosyltransferase 1A7 Genetic Polymorphisms Are Associated with Hepatocellular Carcinoma Risk and Onset Age
C. Tseng (2005)
Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk
M. McGrath (2009)
Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women.
A. Tsezou (2007)
S 251659–1672. Nagar (2004)
The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians.
C. Gallagher (2007)
Variability and Function of Family 1 Uridine-5′-Diphosphate Glucuronosyltransferases (UGT1A)
C. P. Strassburg (2008)
Global cancer statistics, 2012
L. Torre (2015)
Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy.
A. Hood (1999)
Polymorphisms of UGT1A7 and XRCC1 are associated with an increased risk of hepatocellular carcinoma in Northeast China
Zhi-fang Jia (2010)
Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes.
J. Fang (2002)
Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk.
D. Grant (2013)
Breast cancer risk associated with genotype polymorphism of the catechol estrogen‐metabolizing genes: A multigenic study on cancer susceptibility
Ting-Chih Cheng (2005)
Inherited genetic susceptibility to monoclonal B-cell lymphocytosis.
Dalemari Crowther-Swanepoel (2010)
UDP-Glucuronosyltransferase 1A10: Activity against the Tobacco-Specific Nitrosamine, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a Potential Role for a Novel UGT1A10 Promoter Deletion Polymorphism in Cancer Susceptibility
R. Balliet (2010)
Systemic therapy for squamous cell carcinoma of the head and neck.
P. Pancari (2015)
UGT1A1*28 polymorphism in ovarian cancer patients.
E. Cecchin (2004)
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
B. Cole (2009)
Variability and function of family
CP Strassburg (2008)
Age‐specific association of steroid hormone pathway gene polymorphisms with breast cancer risk
D. Ralph (2007)
The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis
L. Yao (2010)
Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population.
H. Okugi (2006)
Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate
A-H Karypidis (2008)
UGT2B17 Polymorphism and Risk of Prostate Cancer: A Meta-Analysis
Marce-Amara Kpoghomou (2013)
Metabolism of N-acetylbenzidine and initiation of bladder cancer.
T. Zenser (2002)
Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
D. Turgeon (2001)
Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats.
R. Barter (1994)
Glucuronidation of PhIP and N-OH-PhIP by UDP-glucuronosyltransferase 1A10.
R. Dellinger (2007)
Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
D. Hein (1993)
Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase*
P. Mackenzie (2008)
Isolation and Characterization of a Novel cDNA Encoding a Human UDP-Glucuronosyltransferase Active on C19 Steroids*
M. Beaulieu (1996)
Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
A. Chan (2005)
UGT1A6 Polymorphisms Modulated Lung Cancer Risk in a Chinese Population
Ley-Fang Kua (2012)
S 29043–51.Nagar (2006)
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.
W. Chow (1995)
Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene.
E. Levesque (1999)
Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man.
P. Bosma (1994)
A randomized trial of aspirin to prevent colorectal adenomas.
J. Baron (2003)
UGT3A: novel UDP-glycosyltransferases of the UGT superfamily
R. Meech (2010)
Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk
J. Wang (2013)
Breast and prostate cancer: more similar than different
G. Risbridger (2010)
study of prostate cancer
H Maier (1992)
An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China.
G. Lin (2005)
Cigarette Smoking and Lung Cancer: Modeling Effect Modification of Total Exposure and Intensity
J. Lubin (2007)
No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARδ and PPAR&ggr; act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma
L. McGreavey (2005)
Effects of Combined UDP-Glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on Paracetamol Pharmacokinetics in β-Thalassemia/HbE
Jeeranut Tankanitlert (2006)
Pharmacogenomics of human UDP-glucuronosyltransferase enzymes
C. Guillemette (2003)
Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer
S. Nagar (2006)
UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics: II. Functional Impact of the Three Most Common Nonsynonymous UGT1A6 Polymorphisms (S7A, T181A, and R184S)
S. Krishnaswamy (2005)
Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation
N. Hanioka (2011)
Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk
M. Lacko (2013)
Association of SULT1A1 and UGT1A1 polymorphisms with breast cancer risk and phenotypes in Russian women
E. Shatalova (2006)
Genotype–phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes
P. Lazarus (2005)
Carcinogenic factors in food with relevance to colon cancer development.
M. Nagao (1993)
Effects of Microsomal Enzyme Inducers on Thyroid Follicular Cell Proliferation and Thyroid Hormone Metabolism
C. Klaassen (2001)
Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview
C. Guillemette (2004)
UDPglucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: A differential impact according to seropositivity of HBV or HCV markers? BMC Cancer 7:214
I Stucker (2007)
Global cancer statistics
A. Jemal (2011)
Molecular Pathways in Prostate Cancer
E. Mazaris (2013)
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.
P. Mackenzie (1997)
Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
W. Samowitz (2006)
A pooled analysis of case–control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea
W. Mack (2004)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
R. Sandler (2003)
The Configuration of the 17-Hydroxy Group Variably Influences the Glucuronidation of β-Estradiol and Epiestradiol by Human UDP-Glucuronosyltransferases
Katriina Itäaho (2008)
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans.
C. Guillemette (2000)
An Allele-Specific Polymerase Chain Reaction Method for the Determination of the D85Y Polymorphism in the Human UDPGlucuronosyltransferase 2B15 Gene in a Case-Control Study of Prostate Cancer
S. Macleod (2000)
Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease.
J. Lin (2010)
Treatment of Hepatocellular Carcinoma: A Systematic Review
S. Lin (2012)
Genetic polymorphism in UDP-glucuronosyltransferase 2B7 and colorectal cancer risk.
E. M. J. van der Logt (2009)
Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides.
M. Ciotti (1999)
Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues.
Zhong Zheng (2002)
The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma
A. Chan (2011)
Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population
Xiaoyi Cui (2012)
[Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
E. Shatalova (2006)
UDP-Glucuronosyltransferase (UGT) 2B15 Pharmacogenetics: UGT2B15 D85Y Genotype and Gender Are Major Determinants of Oxazepam Glucuronidation by Human Liver
M. Court (2004)
Tobacco and alcohol and the risk of head and neck cancer
H. Maier (2004)
Ovarian Cancer Risk and Polymorphisms Involved in Estrogen Catabolism
S. Holt (2007)
Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.
L. Cai (2012)
Refining the UGT1A Haplotype Associated with Irinotecan-Induced Hematological Toxicity in Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Irinotecan-Based Regimens
E. Levesque (2013)
The changing epidemiology of esophageal cancer.
W. Blot (1999)
The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases.
C. Jin (1993)
Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer.
J. Park (2004)
The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk
Andrea Y. Angstadt (2013)
The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26.
A. Bosio (1996)
Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia.
R. Guignard (2007)
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
T. Rebbeck (2006)
UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics: I. Identification of Polymorphisms in the 5′-Regulatory and Exon 1 Regions, and Association with Human Liver UGT1A6 Gene Expression and Glucuronidation
S. Krishnaswamy (2005)
Diet and Health Study
CL Meinhold (2010)
Cigarette Smoking and Lung Cancer: Modeling Total Exposure and Intensity
J. Lubin (2006)
Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved.
S. Nowell (1999)
Common deletion polymorphisms in the human genome
S. McCarroll (2006)
Tobacco carcinogens, their biomarkers and tobacco-induced cancer
S. Hecht (2003)
Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk
A. Elahi (2003)
[Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
J. Liu (2009)
The UGT2B17 gene deletion is not associated with prostate cancer risk
M. Olsson (2008)
IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A10 (UGT1A10) IN THE DETOXIFICATION OF POLYCYCLIC AROMATIC HYDROCARBONS: DECREASED GLUCURONIDATIVE ACTIVITY OF THE UGT1A10139LYS ISOFORM
R. Dellinger (2006)
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily.
P. Mackenzie (2005)
Breast cancer risk associated with genotype polymorphism of the catechol
TC Cheng (2005)
Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells.
S. Nagar (2004)
Genetic polymorphisms of the uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population
K. Chen (2006)
Transcriptional regulation of human UDP-glucuronosyltransferase genes
D. G. Hu (2014)
The multitude and diversity of environmental carcinogens.
D. Belpomme (2007)
Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer
C. Strassburg (2002)
Environmental and chemical carcinogenesis.
G. Wogan (2004)
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk
S. Selinski (2012)
Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk.
Z. Zheng (2001)
Serum bilirubin and 10-year mortality risk in a Belgian population
E. H. Temme (2004)
Joint Effects between UDP-Glucuronosyltransferase 1A7 Genotype and Dietary Carcinogen Exposure on Risk of Colon Cancer
L. Butler (2005)
A Comprehensive Review of Head and Neck Cancer Rehabilitation: Physical Therapy Perspectives
K. Guru (2012)
Carcinogenic factors in food
T. Sugimura (1993)
Genetic Variants of UGT1A6 Influence Risk of Colorectal Adenoma Recurrence
R. Hubner (2006)
Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
P. Upadhyaya (1999)
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Li Tang (2011)
Formation of mono- and diglucuronides and other glycosides of benzo(a)pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex.
Harald Gschaidmeier (1995)
Molecular pathways in prostate
E 171137–1144. Mazaris (2013)
M 3886–92. McGrath (2009)
A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk
Chang Sun (2011)
Estrogen carcinogenesis in breast cancer.
J. Yager (2006)
Genotypephenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes
P Lazarus (2005)
Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development.
J. Liehr (2001)
Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.
J. Sugatani (2002)
Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7
Walter E. Gall (1999)
Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer.
Marija Hiljadnikova Bajro (2012)
Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health Study
C. Meinhold (2009)
Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians.
R. Sharma (2010)
Searching for Tissue-Specific Expression Pattern-Linked Nucleotides of UGT1A Isoforms
Wei Zhang (2007)
Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk.
E. M. J. van der Logt (2004)
Correlation between UDP-Glucuronosyltransferase Genotypes and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Glucuronidation Phenotype in Human Liver Microsomes
D. Wiener (2004)
High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.
P. Dura (2012)
The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases.
L. Vítek (2007)
UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans.
H. Girard (2008)
Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study.
J. Liu (1995)
Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9.
M. Court (2002)
Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
M. Malfatti (2004)
Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene.
C. Guillemette (2000)
Endogenous carcinogenesis: molecular oncology into the twenty-first century--presidential address.
L. Loeb (1989)
Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.
J. Park (2007)
UGT1A1*28 polymorphism and acute lymphoblastic leukemia in children: a Danish case–control study
J. Petersen (2014)
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi (2006)
CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
J. Bigler (2001)
The Functional UGT1A1 Promoter Polymorphism Decreases Endometrial Cancer Risk
Y. Duguay (2004)
O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9.
Q. Ren (2000)
Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers
I. Szanyi (2012)
Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer
A. Jirásková (2012)
Global cancer statistics
D. Parkin (1999)
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
N. Rothman (2010)
Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines.
S. Hecht (1998)
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk
Dalemari Crowther-Swanepoel (2010)
Relevance of UDPglucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review
JC Stingl (2014)
The UDP-Glucuronosyltransferase 2B17 Gene Deletion Polymorphism: Sex-Specific Association with Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronidation Phenotype and Risk for Lung Cancer
C. Gallagher (2007)
Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: Colon cancer family registry
D. Scherer (2014)
Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers
C. E. Caldon (2014)
The UDPglucuronosyltransferase 2B17 gene deletion polymorphism: Sex-specific association with urinary 4-(methylnitrosamino)1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer
CJ Gallagher (2007)
UGT1A1 Genetic Polymorphisms, Endogenous Estrogen Exposure, Soy Food Intake, and Endometrial Cancer Risk
S. Deming (2008)
The UGT1A6_19_GG genotype is a breast cancer risk factor
Christina Justenhoven (2013)
Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.
C. P. Strassburg (1997)
Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.
F. Haggar (2009)
UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers
Sun-Young Kong (2008)
The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: Haplotype associations and gene–environment interactions
Andrea Y. Angstadt (2014)
Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract.
R. Tukey (2001)
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.
P. Bosma (1995)
Epidemiology and genetic susceptibility to bladder cancer
X. Wu (2008)
Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer.
A. Vogel (2002)
Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer
M. Lacko (2010)
Variability and function of family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A).
C. Strassburg (2008)
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer
O. Adegoke (2004)
Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study.
C. Meinhold (2010)
Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome
G. Monaghan (1996)
Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study
A. Vidal (2013)
Polymorphisms in UDP Glucuronosyltransferase Genes: Functional Consequences and Clinical Relevance
P. Mackenzie (2000)
Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.
W. Tang (2012)
Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.
C. P. Strassburg (1998)
UDP-Glucuronosyltransferase 2B7 C802T (His268Tyr) Polymorphism in Bladder Cancer Cases
A. Zimmermann (2008)
Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene.
M. Raijmakers (2000)
DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients.
P. Borentain (2007)
Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men.
A. Karatzas (2010)
Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
C. P. Strassburg (1999)
UGT1A6 and UGT2B15 Polymorphisms and Acetaminophen Conjugation in Response to a Randomized, Controlled Diet of Select Fruits and Vegetables
Sandi L Navarro (2011)
OGlucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) by human 2B7 and 1A9
Q Ren (2000)
UGT1A6 and UGT2B15
SL Navarro (2011)
A novel functional polymorphism in the uridine diphosphate–glucuronosyltransferase 2B7 promoter with significant impact on promoter activity
Y. Duguay (2004)
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans
D. Huo (2007)
Differential allelic expression of c.1568C4A at UGT2B15 is due to variation in a novel cis-regulatory element in the 30UTR. Gene 481:24–28
C Sun (2011)
Genetic Polymorphisms of UGT1A7 and Cancer Risk: Evidence From 21 Case–Control Studies
Pei-hua Lu (2011)
The association between UGT1A7 polymorphism and cancer risk: a meta-analysis.
Shuang-Xi Han (2012)
Copy‐number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism
V. Ménard (2009)
UGT1A1*28 Polymorphism in Chronic Lymphocytic Leukemia: The First Investigation of the Polymorphism in Disease Susceptibility and Its Specific Cytogenetic Abnormalities
M. Karakosta (2014)
Genotyping of the UDP-glucuronosyltransferase (UGT) 1A7 gene revisited.
A. Vogel (2011)
Genetic Variation of Genes Involved in Dihydrotestosterone Metabolism and the Risk of Prostate Cancer
S. Setlur (2010)
[Correlation of polymorphisms of UDP-glucuronosyltransferase 1A7 gene to genetic susceptibility of lung cancer].
F. Feng (2005)
UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin
Y. Chen (2007)
A Novel Function for UDP Glycosyltransferase 8: Galactosidation of Bile Acids
R. Meech (2015)
Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance.
J. Miners (2002)
Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women
The MARIE-GENICA Consortium on Genetic Susceptibility Risk (2009)
Glucuronidation of carcinogen metabolites by complementary DNA-expressed uridine 5'-diphosphate glucuronosyltransferases.
P. Mackenzie (1993)
Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.
Johanie Lépine (2004)
Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
Nicole V Anayannis (2015)
Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.
M. García-Closas (2013)
No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.
Cheryl-L Thompson (2009)
Inactivation by UDP-glucuronosyltransferase enzymes: The end of androgen signaling
S. Chouinard (2008)
UDP-Glucuronosyltransferase 1A7 Genetic Polymorphisms Are Associated with Hepatocellular Carcinoma in Japanese Patients with Hepatitis C Virus Infection
Y. Wang (2004)
Polymorphisms and Haplotypes of the UDP-Glucuronosyltransferase 2B7 Gene Promoter
D. G. Hu (2014)
Catalog of 86 single-nucleotide polymorphisms (SNPs) in three uridine diphosphate glycosyltransferase genes: UGT2A1, UGT2B15, and UGT8
A. Iida (2002)
Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk
Christina Justenhoven (2010)
Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish
T. Sugimura (2004)
UDP-glucuronosyltransferase 2B17 genotype and the risk of lung cancer among Austrian Caucasians.
Michaela Gruber (2013)
UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations.
J. Lampe (1999)
Cancer statistics, 2015
R. Siegel (2015)
Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study
E. Shatalova (2005)
A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine.
D. Gu (2010)
An allelespecific polymerase chain reaction method for the determination of the D85Y polymorphism in the human
SL MacLeod (2000)
Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7.
Z. Cheng (1998)
UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?
I. Stücker (2007)
Pharmacogenomics of human UDPglucuronosyltransferase enzymes
C. Guillemette (2003)
GLUCURONIDATION OF THE ASPIRIN METABOLITE SALICYLIC ACID BY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES AND HUMAN LIVER MICROSOMES
Gwendolyn E. Kuehl (2006)
Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
D. Wiener (2004)
Genetic polymorphism in the human UGT1A6 (planar phenol) UDPglucuronosyltransferase: Pharmacological implications
M Ciotti (1997)
Association of genotypes of carcinogen‐activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N‐acetyltransferase NAT2, with urothelial cancer in a Japanese population
S. Ozawa (2002)
Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.
C. Guillemette (2001)
Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes.
K. Tang (2005)
Metabolism of Thyroid Hormone
T. Visser (2012)
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients
R. Sparks (2004)
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
V. Ribrag (2009)
The Novel UDP Glycosyltransferase 3A2: Cloning, Catalytic Properties, and Tissue Distribution
P. Mackenzie (2011)
Cancer screening in the United States, 2013
R. Smith (2013)
Genetic Variants in Hormone-Related Genes and Risk of Breast Cancer
T. Clendenen (2013)
Allelic imbalance (AI) identifies novel tissue‐specific cis‐regulatory variation for human UGT2B15
C. Sun (2010)
Nutrition and dietary carcinogens.
T. Sugimura (2000)
Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men
J. Park (2006)
Serum bilirubin levels in the U.S. Population: Gender effect and inverse correlation with colorectal cancer
S. Zucker (2004)
Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?
E. Beutler (1998)
Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.
Jean Thibaudeau (2006)
An analysis of the mainstream smoke chemistry of samples of the U.S. cigarette market acquired between 1995 and 2000.
J. E. Swauger (2002)
Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.
E. Levesque (1997)
Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer
M. Lacko (2009)
A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.
A. Gsur (2002)
Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption.
M. A. Rossing (2000)
Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.
B. Aschebrook-Kilfoy (2012)
UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers.
L. M. G. Limenta (2008)
Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
J. Stingl (2014)
Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications.
M. Ciotti (1997)
A Novel Polymorphism in a Forkhead Box A1 (FOXA1) Binding Site of the Human UDP Glucuronosyltransferase 2B17 Gene Modulates Promoter Activity and Is Associated with Altered Levels of Circulating Androstane-3α,17β-diol Glucuronide
D. G. Hu (2010)
Isolation and characterization of a novel cDNA encoding a human
M Beaulieu (1996)
This paper is referenced by
Identification of key genes and specific pathways potentially involved in androgen-independent, mitoxantrone-resistant prostate cancer
S. Zhu (2019)
Disturbance of Mammary UDP-Glucuronosyltransferase Represses Estrogen Metabolism and Exacerbates Experimental Breast Cancer.
X. Zhou (2017)
Coupled Enzymatic Treatment and Mass Spectrometric Analysis for Identification of Glucuronidated Metabolites in Human Samples
Mario S P Correia (2019)
The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation
Fu-Geng Zhao (2020)
Expression Patterns of Xenobiotic-Metabolizing Enzymes in Tumor and Adjacent Normal Mucosa Tissues among Patients with Colorectal Cancer: The ColoCare Study
Jolantha Beyerle (2019)
Cysteine uptake capacity is a relevant mechanism of resistance to platinum salts, in ovarian cancer
I. Santos (2018)
UDP‐glucuronosyltransferase polymorphisms affect diethylnitrosamine‐induced carcinogenesis in humanized transgenic mice
Steffen Landerer (2020)
Advances in drug metabolism and pharmacogenetics research in Australia
P. Mackenzie (2017)
UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
D. Grant (2017)
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.
R. Meech (2019)
Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany
Eugen Krech (2017)
Molecular Biomarkers and Urinary Bladder Cancer (UBC)
A. Srivastava (2019)
Expression of UDP Glucuronosyltransferases 2B15 and 2B17 Is Associated with Methylation Status in Prostate Cancer cells.
Farideh Shafiee-Kermani (2020)
Association of breast cancer risk with polymorphisms in genes involved in the metabolism of xenobiotics and interaction with tobacco smoking: A gene‐set analysis
T. Berrandou (2019)
A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: Implications for Astragali Radix as a Personalized Medicine
Z. Guo (2019)
Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
C. Xu (2018)
Effect of UDP‐glucuronosyltransferase 1A1 activity on risk for developing Gilbert's syndrome
May-Jen Huang (2019)
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer.
S. Gagno (2020)
Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes
Chan Heo (2019)
Correlation between miRNA-196 a 2 and miRNA-499 polymorphisms and bladder cancer
J. Wang (2016)
Impaired Metabolic Pathways Related to Colorectal Cancer Progression and Therapeutic Implications
Chun-yan Qiu (2020)
Characterization of the Ontogeny of Hepatic UDP‐Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes
Justine Badée (2019)
Chemical Probes for Human UDP‐Glucuronosyltransferases: A Comprehensive Review
Xia Lv (2019)
12‐Hydroxyeicosatetraenoic acid levels are increased in actinic keratoses and squamous cell carcinoma
V. Laquer (2018)
Modification of single-nucleotide polymorphism in a fully humanized CYP3A mouse by genome editing technology
S. Abe (2017)
Genetic polymorphisms in the drug detoxification genes and susceptibility to Urinary Bladder Cancer (UBC)
K. Gautam (2018)
Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression
Éric P. Allain (2020)
The UGTome: the expanding diversity of UDP glycosyltransferases and its impact on small molecule metabolism.
D. G. Hu (2019)
UGT1As and predisposition to liver cancer: Still important, more elusive
P. Pineau (2017)
UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: A systematic review of UGT isoforms for precision medicine.
N. Yang (2017)
Molecular mechanisms of drug resistance in ovarian cancer
Leyla Norouzi-Barough (2018)
A Novel Pathogenic UGT1A1 Variant in a Sudanese Child with Type 1 Crigler-Najjar Syndrome
Walaa Elfar (2019)See more